# A Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small Vessels

> **NCT00371748** · PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 261 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** TAXUS Liberté-SR
- **DEVICE:** TAXUS™ Express2
- **DEVICE:** Express2

## Key facts

- **NCT ID:** NCT00371748
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2006-12
- **Final completion:** 2011-04
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00371748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00371748, "A Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small Vessels". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00371748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*